1180370

Epizyme, Inc. — FEI 3009993613

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 22, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)